论文部分内容阅读
目的 探讨倍他乐克对慢性心力衰竭 (CHF)患者的治疗作用。方法 选取本院 2 0 0 1～ 2 0 0 3年收治的按NYHA分级为Ⅱ～Ⅲ级的CHF患者 6 2例 ,随机分为两组 ,对照组 ( 32例 )给予限盐、强心、利尿、扩血管、ACE Ⅰ联合应用 ,治疗组在对照组治疗的基础上添加倍他乐克治疗 ,分别观察并比较两组患者心功能改善情况、心率和血压治疗前后变化情况。结果 倍他乐克组总有效率为 93 3% ,对照组总有效率 75 % ,两组间差异有显著意义 ( χ2 =4 13,P <0 0 5 ) ,且其他指标均有改善。结论 倍他乐克对慢性心力衰竭有较好的治疗作用
Objective To investigate the therapeutic effect of Betaloc on patients with chronic heart failure (CHF). Methods Sixty two patients with NYHA grade Ⅱ ~ Ⅲ grade NYHA admitted to our hospital from 2001 to 2003 were randomly divided into two groups. The control group (32 cases) Diuretic, vasodilator and ACE Ⅰ. The treatment group was treated with Betaloc on the basis of the control group. The improvement of heart function, changes of heart rate and blood pressure before and after treatment were observed and compared respectively. Results The total effective rate of Betaloc group was 93.3%, and the total effective rate of the control group was 75%. There was significant difference between the two groups (χ2 = 4 13, P <0 05), and other indexes improved. Conclusion Betaloc has a good therapeutic effect on chronic heart failure